Lupin, Zydus India: Examining the Details
Lupin and Zydus Lifesciences enter a licensing pact to co-market semaglutide injection in India, aiming to improve access to therapies for diabetes and obesity.
Read moreLupin and Zydus Lifesciences enter a licensing pact to co-market semaglutide injection in India, aiming to improve access to therapies for diabetes and obesity.
Read moreFollowing strong fourth quarter results, Elbit CEO Bezhalel Machlis discussed the company’s proactive business strategy at a TASE conference.
Read moreCrypto cards force asset sales and tax hits.
Read moreNvidia’s CEO Jensen Huang has been making waves in the tech industry recently with his ambitious predictions about AI and self-driving cars, and but let’s take…
Read moreInvestors in Taiwan’s stock market have been watching with bated breath as developments surrounding the weighted index continued to unfold.
Read moreThe French advanced materials manufacturer Mersen (EPA:MRS) reported fourth quarter sales of €356.
Read moreSygnum says its market-neutral BTC Alpha Fund posted 8.
Read moreIn a year marred by unprecedented economic uncertainties, India’s textile exporters are bracing themselves for the most crucial quarter yet.
Read more